Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer

作者: Stephanie Hunter , Braydon Nault , Kingsley Chukwunonso Ugwuagbo , Sujit Maiti , Mousumi Majumder

DOI: 10.3390/CANCERS11070938

关键词: BiologyCancer researchVascular endothelial growth factor CTumor microenvironmentPI3K/AKT/mTOR pathwayVascular endothelial growth factor ACD31PTENLymphangiogenesisAngiogenesis

摘要: MicroRNAs (miRNAs) are small endogenously produced RNAs, which regulate growth and development, oncogenic miRNA tumor metastasis. Tumour-associated angiogenesis lymphangiogenesis processes involving the release of factors from tumour cells into microenvioronemnt to communicate with endothelial induce vascular propagation. Here, we examined roles cyclo-oxygenase (COX)-2 induced miR526b miR655 in tumour-associated lymphangiogenesis. Ectopic overexpression poorly metastatic estrogen receptor (ER) positive MCF7 breast cancer resulted upregulation markers factor A (VEGFA); VEGFC; VEGFD; COX-2; lymphatic vessel hyaluronan receptor-1 (LYVE1); receptors VEGFR1, VEGFR2, EP4. Further, miRNA-high cell free conditioned media promoted migration tube formation by human umbilical vein (HUVECs), upregulated EP4 expression, showing paracrine stimulation microenvironment. The miRNA-induced phenotypes were abrogated antagonist or PI3K/Akt inhibitor treatments, confirming involvement pathway. Tumour supressor gene PTEN was found be downregulated high cells, that it is a target both miRNAs. inhibits hypoxia-inducible factor-1 (HIF1α) pathway, loss regulation these pathways through results VEGF expression. Moreover, tumors, marker VEGFA VEGFD expression significantly higher compared non-adjacent control, positively correlated VEGFA, VEGFC, VEGFD, CD31, LYVE1 samples. These findings further strengthen role miRNAs as biomarkers potential therapeutic abrogate cancer.

参考文章(44)
Sunyoung Park, Christine M. Sorenson, Nader Sheibani, PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis. Clinical Science. ,vol. 129, pp. 217- 234 ,(2015) , 10.1042/CS20140714
Guangmei Mao, Yan Liu, Xi Fang, Yahan Liu, Li Fang, Lianjun Lin, Xinmin Liu, Nanping Wang, Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer Angiogenesis. ,vol. 18, pp. 373- 382 ,(2015) , 10.1007/S10456-015-9474-5
Qian Ning, Caigang Liu, Lei Hou, Min Meng, Xiaojin Zhang, Minna Luo, Shan Shao, Xiaoxiao Zuo, Xinhan Zhao, Vascular Endothelial Growth Factor Receptor-1 Activation Promotes Migration and Invasion of Breast Cancer Cells through Epithelial-Mesenchymal Transition PLoS ONE. ,vol. 8, pp. e65217- ,(2013) , 10.1371/JOURNAL.PONE.0065217
Jing Hu, Yongxia Cheng, Yuezhen Li, Zaishun Jin, Yanming Pan, Guibo Liu, Songbin Fu, Yafang Zhang, Kejian Feng, Yukuan Feng, microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. European Journal of Cancer. ,vol. 50, pp. 2336- 2350 ,(2014) , 10.1016/J.EJCA.2014.06.005
Sandra Cascio, Aleco D'Andrea, Rita Ferla, Eva Surmacz, Eliana Gulotta, Valeria Amodeo, Viviana Bazan, Nicola Gebbia, Antonio Russo, miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. Journal of Cellular Physiology. ,vol. 224, pp. 242- 249 ,(2010) , 10.1002/JCP.22126
Z OTROCK, R MAHFOUZ, J MAKAREM, A SHAMSEDDINE, Understanding the biology of angiogenesis: Review of the most important molecular mechanisms Blood Cells, Molecules, and Diseases. ,vol. 39, pp. 212- 220 ,(2007) , 10.1016/J.BCMD.2007.04.001
Melanie Weigand, Pia Hantel, Rolf Kreienberg, Johannes Waltenberger, Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Angiogenesis. ,vol. 8, pp. 197- 204 ,(2005) , 10.1007/S10456-005-9010-0
Ramesh Singh, Yin-Yuan Mo, Role of microRNAs in breast cancer. Cancer Biology & Therapy. ,vol. 14, pp. 201- 212 ,(2013) , 10.4161/CBT.23296
Sara M Weis, David A Cheresh, Tumor angiogenesis: molecular pathways and therapeutic targets Nature Medicine. ,vol. 17, pp. 1359- 1370 ,(2011) , 10.1038/NM.2537
Sophia Ran, Lisa Volk, Kelly Hall, Michael J. Flister, Lymphangiogenesis and lymphatic metastasis in breast cancer Pathophysiology. ,vol. 17, pp. 229- 251 ,(2010) , 10.1016/J.PATHOPHYS.2009.11.003